News

doctor notes
AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Subhasis Chatterjee, MD. FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Texas Heart Institute at CHI Baylor St. Lukes, explains the new 2026 expert consensus on heparin induced thrombocytopenia (HIT) released at the American Association for Thoracic Surgery (AATS) 2026 annual meeting. #AATS #AATS2026 #AATS26
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

doctor wrong patient wrong-site surgery medical error malpractice mistake
FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

How expert guidelines have influenced TAVR vs. SAVR decisions

As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease. 

Nicole B. Saphier, MD
Opposition forming against radiologist nominee for surgeon general

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

Siemens Healthineers
Siemens Healthineers shakes up leadership team, cuts profit outlook

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

Thumbnail
PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.
CMS unveils $50 GLP-1 prescriptions for Medicare patients

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

Emergency Department room ED ER EM
Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026
Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.
CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

Heartflow Video
Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.

Around the web

Health Exec
AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Cardiovascular Business
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

Cardiovascular Business
FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

Design by Adaptive Theme